Absorbable Sutures Market Size & Growth Forecast 2027–2036, By Segments (Product, Filament, End Use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Absorbable Sutures Market size was worth USD 3.2 billion in 2026 and is expected to grow at a 5.04% CAGR between 2027 and 2036, reaching USD 5.23 billion by 2036. The industry revenue for 2027 is estimated at USD 3.34 billion.

• Base Year Value (2026): USD 3.2 billion
• CAGR (2027-2036): 5.04%
• Forecast Year Value (2036): USD 5.23 billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Absorbable Sutures Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America holds 34.87% share due to high surgical volumes, widespread use across hospital and ambulatory settings, and established procurement systems ensuring consistent product availability.
  • Asia Pacific is growing at 6.1% CAGR, supported by rising surgical procedures, expanding hospital infrastructure, and increasing access to modern wound closure materials across developing healthcare systems.

• Segment Momentum:

  • Needled Absorbable Sterilized Sutures held a 76.86% share in 2026 due to their ready-to-use design, which improves procedural efficiency, simplifies sterile handling, and supports consistent surgical workflows across diverse procedures.
  • Monofilament is expanding fastest as surgeons increasingly prefer sutures that provide smoother tissue passage, reduced drag, and more controlled placement, aligning with evolving surgical techniques and performance expectations.

• Market Expansion Drivers:

  • Rising global surgical volumes increasing demand for bioresorbable wound closure materials.
  • Advancements in biocompatible suture materials improving healing outcomes and reducing infection risks.
  • Aging population driving higher incidence of chronic diseases requiring surgical interventions.

• Leading Market Participants:

  Major companies in the absorbable sutures market include Johnson & Johnson (United States), B. Braun Melsungen AG (Germany), Teleflex Incorporated (United States), Healthium Medtech Limited (India), DemeTECH Corporation (United States), Samyang Holdings Corporation (South Korea), Internacional Farmacéutica S.A. de C.V. (Mexico), Lotus Surgicals Pvt. Ltd. (India), Medtronic plc (Ireland).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 3.2 billion
  • 2027 Estimated Market Size: USD 3.34 billion.
  • Projected Market Size: USD 5.23 billion by 2036
  • Growth Forecasts: 5.04% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Needled Absorbable Sterilized Sutures (Product) | Multifilament (Filament) | Hospitals & Clinics (End Use) | Cardiac Surgery (Application)
  • Emerging Opportunity Segment: Needled Absorbable Sterilized Sutures (Product) | Monofilament (Filament) | Specialty Centers (End Use) | Orthopedic Surgery (Application)

Market Growth Drivers and Industry Trends

Rising global surgical volumes increasing demand for bioresorbable wound closure materials

Increasing surgical activity across hospitals and ambulatory care settings is creating greater demand for wound closure products that can provide reliable tissue approximation without requiring subsequent removal. The absorbable sutures market will expand with rising procedure volumes because bioresorbable sutures gradually break down within the body after supporting the healing process, making them suitable for a wide range of internal and selected external surgical applications. Their use can reduce the need for follow-up visits associated with suture removal and can support patient convenience during postoperative recovery. Broader adoption across general surgery, gynecological procedures, orthopedic interventions, and other specialties is increasing the utilization of absorbable closure materials.

Advancements in biocompatible suture materials improving healing outcomes and reducing infection risks

Material innovation is improving the performance of absorbable sutures by enhancing biocompatibility, tissue response, handling characteristics, and controlled degradation profiles. These developments will drive the absorbable sutures market as surgeons increasingly seek closure materials that maintain adequate tensile strength during critical stages of healing while minimizing unwanted inflammatory responses. Improved material properties can support more predictable wound healing and reduce tissue irritation associated with poorly tolerated suture materials. Developments in coating technologies and suture design are also helping improve smooth passage through tissue, knot security, and resistance to bacterial adhesion, supporting their use in procedures where postoperative wound management is particularly important.

Aging population driving higher incidence of chronic diseases requiring surgical interventions

Population aging is contributing to a greater prevalence of conditions that frequently require surgical management, including degenerative, cardiovascular, orthopedic, and other chronic disorders. This demographic trend will boost the absorbable sutures market demand as older patients undergo procedures requiring dependable wound closure and tissue repair. Aging patients may also require repeated interventions associated with long-term disease management, increasing the need for surgical consumables across multiple specialties. The suitability of absorbable materials for internal wound closure and their ability to eliminate routine suture-removal procedures can be particularly relevant in surgical care pathways involving older patients with complex healthcare needs.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising global surgical volumes increasing demand for bioresorbable wound closure materials	2.00%	High	North America, Asia Pacific	High	Near Term
Advancements in biocompatible suture materials improving healing outcomes and reducing infection risks	1.70%	High	Europe, North America	High	Mid Term
Aging population driving higher incidence of chronic diseases requiring surgical interventions	1.50%	Moderate	Global	High	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

In the absorbable sutures market, North America accounted for the largest share of 34.87% in 2026, reflecting its mature surgical care infrastructure, established adoption of advanced wound-closure products, and strong emphasis on postoperative patient outcomes. Broad utilization across general surgery, gynecology, cardiovascular procedures, and other surgical specialties supports consistent demand for absorbable sutures. Preference for products that reduce the need for suture removal and support efficient wound management further contributes to their use across hospitals and ambulatory surgical settings.

Asia Pacific represents the fastest-growing region in the absorbable sutures market, supported by expanding healthcare access, increasing surgical activity, and improvements in hospital infrastructure. Rising healthcare expenditure and greater availability of specialized surgical services are widening the addressable patient base, while growing adoption of modern wound-closure technologies is supporting product demand. The increasing focus on efficient postoperative care and minimally invasive surgical approaches is also encouraging wider use of absorbable sutures across the region.

Key Country Insights

United States

Advanced Surgical Adoption

The U.S. absorbable sutures market emphasizes products that support minimally invasive and outpatient surgical procedures. Healthcare providers in the U.S. increasingly prioritize reliable wound closure materials with consistent absorption profiles to improve surgical efficiency and patient recovery.

Japan

Procedure Efficiency Focus

Japan prioritizes absorbable sutures that enable precise tissue approximation while reducing the need for postoperative suture removal. Japanese healthcare facilities emphasize consistent product performance and compatibility with modern surgical workflows across multiple specialties.

South Korea

Innovation in Wound Closure

South Korea strengthens its absorbable sutures market through the adoption of advanced biomaterials and refined surgical techniques. Medical institutions in South Korea seek products that improve handling, reduce tissue reaction, and support efficient postoperative care.

Germany

Precision Surgical Standards

Germany focuses on absorbable sutures that meet stringent clinical performance and quality requirements across general and specialty surgeries. Hospitals in Germany continue adopting advanced suture materials that enhance handling characteristics and support standardized surgical practices.

France

Specialized Clinical Applications

France emphasizes absorbable sutures designed for diverse surgical disciplines, including gastrointestinal, gynecological, and cosmetic procedures. French healthcare providers value products that balance predictable absorption with dependable wound support throughout the healing process.

Italy

Hospital Procurement Alignment

Italy focuses on absorbable sutures that combine clinical reliability with efficient hospital procurement strategies. Surgical centers across Italy continue evaluating products that deliver consistent performance while supporting streamlined inventory management and routine procedural needs.

Segment Leadership and Growth Trends

 

Product Segment Analysis: Needled Absorbable Sterilized Sutures (Largest & Fastest-Growing Segment)

Needled absorbable sterilized sutures dominated the absorbable sutures market and are also projected to be the fastest-growing product segment, accounting for a 76.86% share in 2026. Their strong position reflects the convenience of pre-attached needles and the importance of sterile, ready-to-use suturing products across surgical procedures. Absorbable materials eliminate the need for subsequent suture removal as the material gradually breaks down within the body, supporting their use in procedures where postoperative removal can be undesirable. Continued emphasis on surgical efficiency, infection control, and patient convenience is reinforcing demand for this product category.

Filament Segment Analysis: Multifilament (Largest Segment) vs Monofilament (Fastest-Growing Segment)

Multifilament sutures represented the largest share of the absorbable sutures market, accounting for 59.85% in 2026. Their leading position is supported by favorable handling characteristics, flexibility, and knot security, which can make them suitable for procedures requiring controlled placement and dependable tissue approximation. The braided structure of multifilament sutures can also provide useful handling characteristics during complex surgical procedures. Ongoing demand for reliable wound closure products and the broad applicability of multifilament materials across surgical settings continue to support their established market position.

Monofilament is anticipated to be the fastest-growing filament segment as healthcare providers increasingly prioritize suture characteristics associated with reduced tissue interaction and improved suitability for procedures where minimizing bacterial adherence is important. The single-strand structure can provide a smoother surface and may support applications requiring careful tissue handling. Growing attention to postoperative outcomes, infection prevention, and advanced wound-closure techniques is encouraging interest in monofilament absorbable sutures across a wider range of surgical procedures.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Product	Needled Absorbable Sterilized Sutures, Non-Needled Absorbable Sutures	Needled Absorbable Sterilized Sutures	Needled Absorbable Sterilized Sutures
Filament	Monofilament, Multifilament	Multifilament	Monofilament
End Use	Hospitals & Clinics, Ambulatory Surgical Centers, Specialty Centers, Others	Hospitals & Clinics	Specialty Centers
Application	Ophthalmic Surgery, Cardiac Surgery, Orthopedic Surgery, Neurological Surgery, Others	Cardiac Surgery	Orthopedic Surgery

Competitive Landscape and Market Positioning

Top players in the absorbable sutures market:

1. Johnson & Johnson (United States)

2. B. Braun Melsungen AG (Germany)

3. Teleflex Incorporated (United States)

4. Healthium Medtech Limited (India)

5. DemeTECH Corporation (United States)

6. Samyang Holdings Corporation (South Korea)

7. Internacional Farmacéutica S.A. de C.V. (Mexico)

8. Lotus Surgicals Pvt. Ltd. (India)

9. Medtronic plc (Ireland)

The absorbable sutures market is witnessing ongoing advancements in bio-compatible materials and wound closure technologies aimed at improving healing outcomes and reducing post-surgical complications. Consolidation activities and portfolio expansion strategies are contributing to broader product availability across surgical specialties. Demand for minimally invasive procedures and advanced surgical care solutions continues to encourage innovation within the market.

Industry Development/News

Company Name	Date	Key Development
Donghua University	Oct-24	Researchers developed the bioabsorbable electrical stimulation (BioES) suture, a multi-layer coaxial fiber designed to generate localized electric fields in response to muscle movement. By promoting cell proliferation and migration, this self-powered suture accelerates wound healing by up to 50% and exhibits intrinsic antimicrobial properties. This innovation represents a significant shift from passive wound closure toward active, therapeutic, and degradable surgical devices.
Genesis MedTech	Sep-23	Genesis MedTech received NMPA approval for its triclosan-coated absorbable antimicrobial sutures. Designed to combat resistant bacteria such as MRSA and MRSE, these sutures provide a proactive clinical solution to reduce the incidence of surgical site infections (SSIs). This milestone marks a key expansion for the company’s surgical portfolio, aligning with international WHO and CDC guidelines for infection prevention in high-risk surgical procedures.
Futura Surgicare	Feb-24	Futura Surgicare, manufacturer of the "Dolphin Sutures" brand, entered a consulting services agreement with Novo Integrated Sciences to facilitate the introduction of its high-quality wound closure portfolio into the North American market. This strategic collaboration leverages Futura’s established global distribution and manufacturing capabilities to expand the footprint of its medical-grade sutures, meshes, and bone wax products in Western healthcare systems.
Peters Surgical	Nov-23	Peters Surgical established an exclusive distribution partnership with Vertice Healthcare to expand its footprint in the South African market. The agreement covers the company’s complete range of sutures, surgical clips, and tissue glues. This partnership enhances local availability of advanced surgical closure solutions, supported by Vertice's specialized division network and commitment to providing high-quality, patient-centric surgical technology to South African healthcare professionals.